Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
August 1, 2017
Patent Application Number
15401839
Date Filed
January 9, 2017
Patent Citations Received
Patent Primary Examiner
Patent abstract
Compounds of Formula I: and pharmaceutically acceptable salts thereof, wherein ring A, ring B, W, m, D, R2, R2a, R3, R3a, and Z are as defined herein, are inhibitors of Trk kinases and are useful in the treatment of pain, cancer, inflammation, neurodegenerative diseases and certain infectious diseases.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
